IL118219A0 - Antifungal compositions - Google Patents

Antifungal compositions

Info

Publication number
IL118219A0
IL118219A0 IL11821995A IL11821995A IL118219A0 IL 118219 A0 IL118219 A0 IL 118219A0 IL 11821995 A IL11821995 A IL 11821995A IL 11821995 A IL11821995 A IL 11821995A IL 118219 A0 IL118219 A0 IL 118219A0
Authority
IL
Israel
Prior art keywords
pct
date nov
azole
sec
antifungal compositions
Prior art date
Application number
IL11821995A
Other languages
English (en)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL118219A0 publication Critical patent/IL118219A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Materials For Medical Uses (AREA)
IL11821995A 1995-05-12 1996-05-10 Antifungal compositions IL118219A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9509631.9A GB9509631D0 (en) 1995-05-12 1995-05-12 Antifungal combination

Publications (1)

Publication Number Publication Date
IL118219A0 true IL118219A0 (en) 1996-09-12

Family

ID=10774361

Family Applications (2)

Application Number Title Priority Date Filing Date
IL11821995A IL118219A0 (en) 1995-05-12 1996-05-10 Antifungal compositions
IL11821996A IL118219A (en) 1995-05-12 1996-05-10 Antifungal compositions comprising terbinafine and an azole, their use in the preparation of a medicament and process for their preparation

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL11821996A IL118219A (en) 1995-05-12 1996-05-10 Antifungal compositions comprising terbinafine and an azole, their use in the preparation of a medicament and process for their preparation

Country Status (26)

Country Link
US (1) US5985906A (da)
EP (1) EP0824350B1 (da)
JP (1) JPH11504931A (da)
KR (1) KR100443535B1 (da)
CN (1) CN1100539C (da)
AT (1) ATE246504T1 (da)
AU (1) AU712914B2 (da)
CA (1) CA2219651C (da)
CY (1) CY2496B1 (da)
CZ (1) CZ291144B6 (da)
DE (1) DE69629367T2 (da)
DK (1) DK0824350T3 (da)
ES (1) ES2205042T3 (da)
FI (1) FI120079B (da)
GB (1) GB9509631D0 (da)
HK (1) HK1016064A1 (da)
HU (1) HU224920B1 (da)
IL (2) IL118219A0 (da)
MX (1) MX9708699A (da)
NO (1) NO317030B1 (da)
PL (1) PL322749A1 (da)
PT (1) PT824350E (da)
SK (1) SK150797A3 (da)
TW (1) TW464492B (da)
WO (1) WO1996035423A1 (da)
ZA (1) ZA963754B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187757B1 (en) * 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
US7067526B1 (en) 1999-08-24 2006-06-27 Ariad Gene Therapeutics, Inc. 28-epirapalogs
EP1212331B1 (en) * 1999-08-24 2004-04-21 Ariad Gene Therapeutics, Inc. 28-epirapalogs
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
US6673373B2 (en) 2001-02-01 2004-01-06 Carlsbad Technology Inc. Antifungal formulation and the methods for manufacturing and using the same
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
EP2181704B1 (en) 2002-12-30 2015-05-06 Angiotech International Ag Drug delivery from rapid gelling polymer composition
CN1913912B (zh) 2003-12-08 2010-06-16 Cpex药品公司 用于胰岛素治疗的药用组合物及方法
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
NZ561675A (en) 2005-04-07 2010-07-30 Toyama Chemical Co Ltd Pharmaceutical composition and method using antifungal agent in combination
ATE538789T1 (de) 2006-10-06 2012-01-15 Toyama Chemical Co Ltd Pharmazeutische zusammensetzung mit einem phenylamidin-derivat und verfahren zur verwendung der pharmazeutischen zusammensetzung in kombination mit einem antimykotischen mittel
EP2121572A2 (en) * 2006-12-08 2009-11-25 Auspex Pharmaceuticals Inc. Preparation and utility of substituted allylamines
EP2245165A4 (en) 2008-01-11 2011-06-01 Massachusetts Eye & Ear Infirm TRANSGENIC CONDITIONAL STOP DIMERICABLE CASPASE ANIMALS
JP6525971B2 (ja) 2013-06-11 2019-06-05 タカラ バイオ ユーエスエー， インコーポレイテッド タンパク質富化微細小胞、タンパク質富化微細小胞の作製方法及び使用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144346A (en) * 1977-01-31 1979-03-13 Janssen Pharmaceutica N.V. Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles
US4218458A (en) * 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
GB2099818A (en) * 1981-06-06 1982-12-15 Pfizer Ltd Triazoles
US4782059A (en) * 1986-09-29 1988-11-01 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
JP2581707B2 (ja) * 1987-10-02 1997-02-12 科研製薬株式会社 抗真菌剤組成物
CA2016738A1 (en) * 1989-06-08 1990-12-08 Philippe Guerry Substituted aminoalkylbenzene derivatives
JPH0338521A (ja) * 1989-07-05 1991-02-19 Maruho Kk 抗真菌性組成物
JPH0338522A (ja) * 1989-07-05 1991-02-19 Maruho Kk 抗真菌性組成物
CA2020888A1 (en) * 1989-07-27 1991-01-28 Philippe Guerry Substituted aminoalkoxybenzene derivatives
US5214046A (en) * 1989-07-27 1993-05-25 Hoffmann-La Roche Inc. Substituted aminoalkoxybenzene anti-fungicidal compositions and use
CA2044533A1 (en) * 1990-06-29 1991-12-30 Philippe Guerry Substituted aminoalkylbiphenyl derivatives
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
JP3038521U (ja) 1996-12-05 1997-06-20 啓次 小峰 排泄物一時保持具用の水溶繊維製ステック状吸液材
JP3038522U (ja) 1996-12-05 1997-06-20 秀俊 筬 カード型紙箱ポプリ

Also Published As

Publication number Publication date
CN1184427A (zh) 1998-06-10
FI973812A0 (fi) 1997-09-26
EP0824350B1 (en) 2003-08-06
HUP9801140A2 (hu) 1999-01-28
HU224920B1 (en) 2006-04-28
FI973812A (fi) 1997-11-11
DE69629367D1 (de) 2003-09-11
CZ354797A3 (cs) 1998-02-18
ZA963754B (en) 1997-11-10
PL322749A1 (en) 1998-02-16
AU712914B2 (en) 1999-11-18
SK150797A3 (en) 1998-05-06
PT824350E (pt) 2003-12-31
AU5818396A (en) 1996-11-29
US5985906A (en) 1999-11-16
CY2496B1 (en) 2005-09-02
CN1100539C (zh) 2003-02-05
NO317030B1 (no) 2004-07-26
HUP9801140A3 (en) 2000-07-28
CZ291144B6 (cs) 2002-12-11
IL118219A (en) 2001-08-26
MX9708699A (es) 1998-02-28
CA2219651C (en) 2007-03-27
TW464492B (en) 2001-11-21
WO1996035423A1 (en) 1996-11-14
DK0824350T3 (da) 2003-11-03
DE69629367T2 (de) 2004-06-09
JPH11504931A (ja) 1999-05-11
EP0824350A1 (en) 1998-02-25
ATE246504T1 (de) 2003-08-15
NO975134D0 (no) 1997-11-07
NO975134L (no) 1997-11-07
GB9509631D0 (en) 1995-07-05
KR100443535B1 (ko) 2004-12-17
HK1016064A1 (en) 1999-10-29
CA2219651A1 (en) 1996-11-14
KR19990014708A (ko) 1999-02-25
ES2205042T3 (es) 2004-05-01
FI120079B (fi) 2009-06-30

Similar Documents

Publication Publication Date Title
IL118219A0 (en) Antifungal compositions
IL139080A0 (en) Btx inhibitors and methods for their indentification and use
PL361233A1 (en) Efficient ligand-mediated ullmann coupling of anilines and azoles
PT1355889E (pt) Derivados diamina triazole substituidos como inibidores de cinase
WO1999047131A3 (en) Combination of a gaba-a alpha 5 inverse agonist and an acetylcholinesterase inhibitor
ATE222100T1 (de) Amidino-derivate nützlich als no synthase-hemmer
GB9317636D0 (en) Use of dexmedetomidine
ITBO970019A0 (it) Macchina e metodo per la composizione di mazzette di foglietti, in par ticolare banconote.
NZ300942A (en) 1-aryl-2-acylamino-ethane derivatives as neurokinin 1 antagonists
PL324625A1 (en) Fungicidal compositions
IL116887A0 (en) Cationic copolymers of vinyl amine and vinyl alcohol for the delivery of oligonucleotides
RS51092B (sr) Escitalopram bromhidrat i postupak za njegovo pripremanje
PT1235579E (pt) Composicoes farmaceuticas contendo trimegestona
IL152908A0 (en) USE OF (+)-a- (2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL) ETHYL] -4-PIPERIDINEMETHANOL OR ITS PRODRUG IN THE TREATMENT OF SYMPTOMS OF DEMENTIA AND DOPAMINE INDUCED PSYCHOSIS
HK1018618A1 (en) Process for preparing 1,4,7,10-tetraazacyclododecane and its derivatives
ATE213782T1 (de) Verfahren zur biotransformation von colchicinoid- verbindungen in die entsprechenden 3- glycosylderivate
WO2001004354A3 (en) Use of ras inhibitors of inhibiting muscle atrophy
NZ241234A (en) Amino polyhydroxy cyclohexane derivatives and medicaments
MX9603305A (es) Proceso mejorado para la ruptura de emulsiones de aceite.
IT1281265B1 (it) Pressa punzonatrice-roditrice per lamiere metalliche, o simili.
ITMI20000908A0 (it) Metodo e sistema per l'assicurazione di un investimento in titoli azionari e similari.
GR3034079T3 (en) Method for preparing 3-amino-2-chloro-4-alkylpyridine or -4-arylpyridine.
DE59702821D1 (en) Dimethyl-substituierte cyclohexandienderivate
UA42111C2 (uk) Засіб для прихованого маркування небіологічних об'єктів
GEP20033018B (en) Method for Flexographic Printing